Boehringer Ingelheim Venture Fund's book
21 companies · priced for members| Company | Industry | Valuation | $/share | First invested | Role |
|---|---|---|---|---|---|
| AgomAb | Drug Discovery | ▮ | ▮ | ▮ | ▮ |
| Rgenta Therapeutics | — | ▮ | ▮ | ▮ | ▮ |
| Wellth (Healthcare Technology Systems) | — | ▮ | ▮ | ▮ | ▮ |
+ 18 more companies · all 21, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Boehringer Ingelheim Venture Fund portfolio at a glance
21 portfolio companies are on record for Boehringer Ingelheim Venture Fund, including AgomAb, Rgenta Therapeutics and Wellth (Healthcare Technology Systems).
14 of the 21 carry a recorded valuation.
Free account
See more of the book
- ·The top 10 names in the book — of 21 recorded positions
- ·Watchlist + alerts for Boehringer Ingelheim Venture Fund's activity